Annals of the Rheumatic Diseases

ASAS consensus definition of early axial spondyloarthritis.

Annals of the Rheumatic Diseases

Navarro-Compán V, Benavent D, Capelusnik D, van der Heijde D, Landewé RB, Poddubnyy D, van Tubergen A, Baraliakos X, Van den Bosch FE, van Gaalen FA, Gensler L, López-Medina C, Marzo-Ortega H, Molto A, Pérez-Alamino R, Rudwaleit M, van de Sande M, Sengupta R, Weber U, Ramiro S

POS0657 LONG-TERM SAFETY OF UPADACITINIB IN PSORIATIC ARTHRITIS, ANKYLOSING SPONDYLITIS, AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS UP TO 5 YEARS.

Annals of the Rheumatic Diseases

G.R. Burmester, J. Stigler, A. Rubbert-Roth, Y. Tanaka, V.F. Azevedo, D. Coombs, R. Mccaskill, R. Lippe, P. Wung, L.S. Gensler

POS0417 ACTIVATED NEUTROPHILS DEGRADE CARTILAGE ENDPLATES.

Annals of the Rheumatic Diseases

I. Heggli, M. Habib, J. Scheer, N. Herger, T. Mengis, C. Laux, F. Wanivenhaus, J.M. Spirig, M. Betz, M. Farshad, O. Distler, A. Fields, S. Dudli

POS0665 INCIDENCE RATE AND FACTORS ASSOCIATED WITH FRACTURES AMONG ADULTS WITH ANKYLOSING SPONDYLITIS IN THE UNITED STATES.

Annals of the Rheumatic Diseases

R. Stovall, E. Kersey, J. LI, R. Baker, C. Anastasiou, A. Palmowski, G. Schmajuk, L. S. Gensler, J. Yazdany

POS1115 EFFECT OF SECUKINUMAB VERSUS ADALIMUMAB BIOSIMILAR ON RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: SUBGROUP ANALYSES BY BASELINE SYNDESMOPHYTES AND C-REACTIVE PROTEIN STATUS.

Annals of the Rheumatic Diseases

X. Baraliakos, D. Van der Heijde, P. Machado, V. Navarro-Compán, L. S. Gensler, P. Pertel, E. Quebe-Fehling, A. Readie, H. Richards, D. Poddubnyy

POS1103 BIMEKIZUMAB MAINTAINED IMPROVEMENTS IN EFFICACY ENDPOINTS AND HAD A CONSISTENT SAFETY PROFILE THROUGH 52 WEEKS IN PATIENTS WITH NON-RADIOGRAPHIC AND RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: RESULTS FROM TWO PARALLEL PHASE 3 STUDIES.

Annals of the Rheumatic Diseases

X. Baraliakos, A. Deodhar, D. Van der Heijde, M. Magrey, W. P. Maksymowych, T. Tomita, H. Xu, M. Oortgiesen, U. Massow, C. Fleurinck, A. Ellis, T. Vaux, J. Smith, A. Marten, L. S. Gensler

POS0683 AN EXPLORATORY ANALYSIS OF THE POTENTIAL DISCONNECT BETWEEN OBJECTIVE INFLAMMATORY RESPONSE AND CLINICAL RESPONSE FOLLOWING CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS.

Annals of the Rheumatic Diseases

M. Rudwaleit, F. Van den Bosch, H. Marzo-Ortega, V. Navarro-Compán, R. Tham, T. Kumke, L. Bauer, M. Kim, L. S. Gensler

POS0668 LOW UVEITIS RATES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS TREATED WITH BIMEKIZUMAB: POOLED RESULTS FROM PHASE 2B/3 TRIALS.

Annals of the Rheumatic Diseases

M. Rudwaleit, M. Brown, F. A. Van Gaalen, N. Haroon, L. S. Gensler, C. Fleurinck, A. Marten, U. Massow, N. De Peyrecave, T. Vaux, K. White, A. Deodhar, I. Van der Horst-Bruinsma

OP0059 EFFECT OF SECUKINUMAB VERSUS ADALIMUMAB BIOSIMILAR ON RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: A RANDOMISED PHASE IIIB STUDY.

Annals of the Rheumatic Diseases

X. Baraliakos, M. Østergaard, D. Poddubnyy, D. Van der Heijde, A. Deodhar, P. Machado, V. Navarro-Compán, K. G. Hermann, M. Kishimoto, E. Y. Lee, L. S. Gensler, U. Kiltz, M. Eigenmann, P. Pertel, A. Readie, H. Richards, B. Porter, J. Braun

OP0055 ASAS CONSENSUS DEFINITION OF EARLY AXIAL SPONDYLOARTHRITIS.

Annals of the Rheumatic Diseases

V. Navarro-Compán, D. Benavent, D. Capelusnik, D. Van der Heijde, R. B. M. Landewé, D. Poddubnyy, A. Van Tubergen, X. Baraliakos, F. Van den Bosch, F. A. Van Gaalen, L. S. Gensler, C. López-Medina, H. Marzo-Ortega, A. Moltó, R. Perez Alamino, M. Rudwaleit, M. G. H. Van de Sande, R. Sengupta, U. Weber, S. Ramiro

Pages